Cargando…
Case report: Camrelizumab associated with central retinal vein occlusion
Immunotherapy has revolutionized cancer treatment and become one of the five pillars of cancer therapy. The clinical applications of immunotherapy have been adapted to range from the management of melanoma to most tumor types. As the clinical applications of cancer immunotherapies expand, understand...
Autores principales: | Zhan, Yixiang, Zhao, Weipeng, Ni, Kemin, Liu, Zhaoce, Su, Yanjun, Li, Xichuan, Zhang, Heng, Zhang, Chunze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726748/ https://www.ncbi.nlm.nih.gov/pubmed/36505454 http://dx.doi.org/10.3389/fimmu.2022.1025125 |
Ejemplares similares
-
Branch Retinal Vein Occlusion followed by Central Retinal Vein Occlusion
por: Moradian, Siamak, et al.
Publicado: (2009) -
Central retinal vein occlusion and branch retinal vein occlusion in the same eye
por: Sundar, M Dheepak, et al.
Publicado: (2019) -
Camrelizumab plus platinum-irinotecan followed by maintenance camrelizumab plus apatinib in untreated extensive-stage small-cell lung cancer: a nonrandomized clinical trial
por: Ni, Jun, et al.
Publicado: (2023) -
Combined central retinal vein occlusion and branch retinal artery occlusion
por: Goel, Sugandha, et al.
Publicado: (2018) -
Characterization of Macrophage-Like Cells in Retinal Vein Occlusion Using En Face Optical Coherence Tomography
por: Zeng, Yunkao, et al.
Publicado: (2022)